PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 17, 2021European Heart Journal - Cardiovascular Pharmacotherapy21 citationsOpen Access

Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry

View Full Paper
CKChris J. KapeliosLLLars H. LundLBLina Benson

Structured PICO

Does digoxin use improve mortality/morbidity in patients with contemporary heart failure with reduced ejection fraction?

P
Population
Patients with contemporary heart failure with reduced ejection fraction (HFrEF) from the Swedish Heart Failure Registry
I
Intervention
Digoxin
O
Outcome
Mortality/morbiditycomposite

In contemporary HFrEF, digoxin use is associated with lower mortality/morbidity in patients with atrial fibrillation, but higher mortality/morbidity in those without atrial fibrillation.

Abstract

The great majority of digoxin users had a history of AF. Digoxin use was associated with lower mortality/morbidity in patients with AF, but with higher mortality/morbidity in patients without AF.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kapelios et al. (2021) studied this question.

synapsesocial.com/papers/69d575155f8349d3f7ad4f96https://doi.org/10.1093/ehjcvp/pvab079
Ask AI
Helpful
Bookmark
Share
View Full Paper